86051-75-4 Usage
Description
1,2-Dimethyl-5-tributylstannanyl-1H-imidazole is a chemical compound characterized by a 1H-imidazole ring with two methyl groups and a tributylstannyl group attached to the 1 and 2 positions. 1,2-Dimethyl-5-tributylstannanyl-1H-imidazole is known for its utility in organic synthesis and as a catalyst in various chemical reactions.
Uses
Used in Organic Synthesis:
1,2-Dimethyl-5-tributylstannanyl-1H-imidazole is used as a reagent in organic synthesis for the formation of carbon-carbon and carbon-nitrogen bonds, facilitating the creation of complex organic molecules.
Used as a Catalyst in Chemical Reactions:
In the chemical industry, 1,2-Dimethyl-5-tributylstannanyl-1H-imidazole is utilized as a catalyst to enhance the efficiency of various chemical reactions, including cross-coupling reactions and halogenation processes, thereby improving the yield and selectivity of desired products.
Used in Medicinal Chemistry:
1,2-Dimethyl-5-tributylstannanyl-1H-imidazole has potential applications in medicinal chemistry, where its structure and properties are being investigated for possible use in the development of pharmaceuticals, given its unique chemical characteristics.
Check Digit Verification of cas no
The CAS Registry Mumber 86051-75-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,6,0,5 and 1 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 86051-75:
(7*8)+(6*6)+(5*0)+(4*5)+(3*1)+(2*7)+(1*5)=134
134 % 10 = 4
So 86051-75-4 is a valid CAS Registry Number.
InChI:InChI=1/C5H7N2.3C4H9.Sn/c1-5-6-3-4-7(5)2;3*1-3-4-2;/h3H,1-2H3;3*1,3-4H2,2H3;/rC17H34N2Sn/c1-6-9-12-20(13-10-7-2,14-11-8-3)17-15-18-16(4)19(17)5/h15H,6-14H2,1-5H3
86051-75-4Relevant articles and documents
MACROCYCLIC AZOLOPYRIDINE DERIVATIVES AS EED AND PRC2 MODULATORS
-
Paragraph 1036, (2020/10/09)
The invention relates to modulators of Embryonic Ectoderm Development (EED) and/or Polycomb Repressive Complex 2 (PRC2) useful in the treatment of disorders and diseases associated with EEC and PRC2, being macrocyclic azolopyridine derivatives and compositions thereof of Formula (I), or a pharmaceutically acceptable salt, prodrug, solvate, hydrate, enantiomer, isomer, or tautomer thereof, wherein X1, X2, X3, A1, A2, Y, R1, R2, R3, and R4 are as described herein.
